Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Amgen Hits Another Emerging Market Target With $700M Turkish Deal

Apr 25 2012

• By Emily Hayes

Related Content

Epogen Facing Sales Hit With Reduced Dosing Instructions In ESA Labeling For Renal Disease

Jun 24 2011

Amgen Planned Acquisition Of KAI Would Bring In Replacement For Sensipar

Apr 10 2012

Will New Injectables Sell In An Oral, Mainly Generic Cholesterol World?

Apr 09 2012

After Brazil Onto China? Amgen Unveils Emerging Market Strategy

Apr 26 2011

A Maturing Amgen Focuses On Capital Allocation, Late-Stage Pipeline

Oct 24 2011

Related Companies

Amgen, Inc.

Pfizer Inc.

GSK plc

Merck & Co., Inc.

Amgen, Inc.

Affymax, Inc.

Fresenius SE & Co. KGaA

Novartis AG

KAI Pharmaceuticals

AstraZeneca PLC

MedImmune LLC

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window